Appropriations funding is a critical resource in supporting agencies focused on kidney research and public health. These funds allow agencies to support research, award grants to community-based organizations, and make advancements in the development of new life-saving medical treatment and drugs. The National Institutes of Health (NIH) and Center for Disease Control and Prevention (CDC) rely on the United States Congress for the funding needed to deliver services and programs to improve the lives of patients with end stage renal disease (ESRD).

The American Kidney Fund supports increased appropriations funding to ensure that there are adequate funding levels for programs focused on patients with kidney disease.

Kidney Research Funding

Medical research is critical to finding a cure for kidney disease. Kidney disease research is funded through the National Institute of Diabetes, Digestive and Kidney Disease (NIDDK), which is part of the National Institutes of Health (NIH). The amount of research dollars allocated for kidney disease research needs to be increased. There are currently 30 million Americans with kidney disease, and the amount allocated for research for kidney disease was $585 million in FY 2014. The amount is small when compared with FY 2014 funding level for other diseases: HIV/AIDS was funded $2.9 billion; cancer was funded at $7.9 billion; and heart disease was funded at $1.6 billion. The American Kidney Fund works to increase funding of kidney disease research.

The Chronic Kidney Disease (CKD) Initiative

The Centers for Disease Control (CDC) classifies chronic kidney disease (CKD) as a serious public health issue and is recognized as the ninth leading cause of death in the United States. The CDC’s Chronic Kidney Disease (CKD) Initiative was mandated by congress in 2006 to help solve the growing problem of kidney disease. The CKD Initiative currently funds projects such as surveillance, epidemiology, state-demonstration projects, and economic studies. Early detection and treatment of patients with CKD can help prevent or delay cardiovascular death and progression to kidney failure. Since the program’s inception, Congress has provided direct funding for CKD program at approximately 2.2 million per year.  AKF supports increased funding for CKD Initiative to help support more research and other related initiatives on prevention, education and research.